Dear Colleagues: As you know, neoadjuvant treatment of thymic epithelial tumors (TET) might increase their resectability. Unlike in lung carcinoma, in the thymus, the effect of neoadjuvant treatment has not […]
Dear ITMIG Colleagues, With great excitement we can report that the ITMIG prospective database is reshaping up to be a resounding success. The HUBzero platform that was previously used has […]
Dear ITMIG Member, The Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group (ITMIG) is interested in examining outcomes for patients with thymic carcinomas and thymomas, and […]
ITMIG is an international platform of thymic malignancies. Thymic malignancies are associated with paraneoplastic/autoimmune syndromes. MYASTHENIA GRAVIS is the most common syndrome associated with thymic malignancies. Neurologists treating myasthenia gravis […]
